Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 9/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16390247 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL16389897 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL16390572 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL16390218 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL381606 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL16390287 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL16638649 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL9016915 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL16390227 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B | |
| SCHEMBL16389976 | 1.00 | EPHX1 (0.46) | EPHX1ALDH1A1KDM4ETSHRADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2826845-B1 | SLIDING MECHANISM WITH LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO (JP) | 2021-03-10 | — | — | EP | disclosed |
| US-9803155-B2 | Lubricating oil composition, and sliding mechanism using lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9593291-B2 | Lubricating oil composition, and sliding mechanism using lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20150080277-A1 | LUBRICATING OIL COMPOSITION, AND SLIDING MECHANISM USING LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2015-03-19 | — | — | US | disclosed |
| US-20150036962-A1 | LUBRICATING OIL COMPOSITION, AND SLIDING MECHANISM USING LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2015-02-05 | — | — | US | disclosed |
| EP-2826844-A1 | LUBRICATING OIL COMPOSITION, AND SLIDING MECHANISM USING LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co., Ltd (JP) | 2015-01-21 | — | — | EP | disclosed |
| EP-2826845-A1 | LUBRICATING OIL COMPOSITION, AND SLIDING MECHANISM USING LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co., Ltd (JP) | 2015-01-21 | — | — | EP | disclosed |
| WO-2011101348-A1 | LUBRICATING OIL COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2011-08-25 | — | — | WO | disclosed |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009641-A1 | Amine-containing lipids and uses thereof | PHOSPHO1, CHMP4B, SGMS1 | EPHX1 914/4885ALDH1A1 1430/4885KDM4E 2172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.